Top Midday Gainers

MT Newswires Live02-18 02:39

The OLB Group (OLB) said Tuesday it entered into a global partner agreement with PayPal (PYPL) to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.

Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.

Polaryx Therapeutics (PLYX) said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.

Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.

Compass Pathways (CMPS) said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.

Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.

Price: 1.24, Change: +0.82, Percent Change: +197.23

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2612898464?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-18 02:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612898464","market":"nz","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> The OLB Group (OLB) said Tuesday it entered into a global partner agreement with <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> (PYPL) to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.</p><p>Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.</p><p>Polaryx <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PLYX) said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.</p><p>Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.</p><p>Compass Pathways (CMPS) said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.</p><p>Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.</p><p>Price: 1.24, Change: +0.82, Percent Change: +197.23</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-18 02:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> The OLB Group (OLB) said Tuesday it entered into a global partner agreement with <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> (PYPL) to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.</p><p>Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.</p><p>Polaryx <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PLYX) said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.</p><p>Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.</p><p>Compass Pathways (CMPS) said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.</p><p>Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.</p><p>Price: 1.24, Change: +0.82, Percent Change: +197.23</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2612898464","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612898464","pubTimestamp":1771353579,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"The OLB Group  said Tuesday it entered into a global partner agreement with PayPal  to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.Polaryx Therapeutics  said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.Compass Pathways  said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.Price: 1.24, Change: +0.82, Percent Change: +197.23","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4139":"生物科技","LU0106831901.USD":"贝莱德世界金融基金A2","LU2360107671.USD":"BGF FINTECH \"A4\" (USD) INC","CMPS":"COMPASS Pathways plc","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","BK4551":"寇图资本持仓","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","PYPG":"2倍做多PYPL ETF- Leverage Shares","BK4106":"数据处理与外包服务","BK4524":"宅经济概念","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","BK4554":"元宇宙及AR概念","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","OLB":"OLB Group Inc","BK4527":"明星科技股","PYPY":"PYPL期权收益策略ETF-YieldMax","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","BK4588":"碎股","BK4534":"瑞士信贷持仓","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU1861217088.USD":"贝莱德金融科技A2","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4227":"交易和支付处理服务","LU1861220207.SGD":"Blackrock FinTech A2 SGD-H","BK4007":"制药","BK4598":"佩洛西持仓","BK4566":"资本集团","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","BK4535":"淡马锡持仓","PLYX":"Polaryx Therapeutics Inc","BK4581":"高盛持仓","LU2089283258.USD":"安联环球可持续基金Cl AM Dis"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OLB":1.95,"PLYX":1.95,"CMPS":1.95,"PYPG":0.6,"PYPY":0.6},"content_text":"The OLB Group (OLB) said Tuesday it entered into a global partner agreement with PayPal (PYPL) to deliver a checkout and wallet experience for merchants across its ecosystem, including its SecurePay payment gateway.Shares of OLB almost tripled, with intraday trading volume catapulting to over 358.3 million from a daily average of about 214,000.Polaryx Therapeutics (PLYX) said Tuesday it selected a contract research organization for the second phase of a trial evaluating the safety, tolerability, and clinical activity of PLX-200 across four lysosomal storage disorders.Shares surged 76% as intraday trading volume soared to over 46.5 million from a daily average of roughly 169,000.Compass Pathways (CMPS) said Tuesday that a second phase 3 trial of COMP360 for treatment-resistant depression achieved its primary endpoint.Shares jumped 37%, with intraday trading volume at over 28.8 million compared with a daily average of about 1.4 million.Price: 1.24, Change: +0.82, Percent Change: +197.23","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2612898464","isCrawlerRequest":true}